1. Sanofi, despite the pandemic, sees early gains from CEO Hudson's strategy — Trump administration to require insurers to cover COVID-19 vaccine — Regeneron/Sanofi's Libtayo gets priority review in NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Midwest Opening

Discussion in 'Vascular Solutions' started by anonymous, Aug 10, 2016 at 6:39 AM.

  1. anonymous

    anonymous Guest

    Looks like there is not a lot of activity on this site, but I thought I would check.

    I was called by a recruiter about an opening or potential opening that would cover areas in the Midwest, mostly in the Kansas City Metro area.

    Does anyone know anything about this opening? Did the person leave, get fired, or was underperforming? I am currently calling on cardiologist in the same industry, but it sounds like this would be a bump in total comp.

    Thanks for any insight.